ZBP1 and Crohn's colitis: This induces ZBP1-mediated PANoptosis in IECs, resulting in impaired intestinal mucosal barrier function and the release of a substantial number of inflammatory cytokines, promoting the progression of Crohn's colitis (Figure 11).